Impact of Glycemic Control Strategies on the Progression of Diabetic Peripheral Neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

(2012) W. H. Herman et al.   DIABETIC MEDICINE

Insulin resistance in the nervous system

(2012) Bhumsoo Kim et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The identification of gene expression profiles associated with progression of human diabetic neuropathy

(2011) Junguk Hur et al.   BRAIN

Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

(2011) Burton E. Sobel et al.   CIRCULATION

Effect of Prior Intensive Insulin Treatment During the Diabetes Control and Complications Trial (DCCT) on Peripheral Neuropathy in Type 1 Diabetes During the Epidemiology of Diabetes Interventions and Complications (EDIC) Study

(2010) J. W. Albers et al.   DIABETES CARE

Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

(2010) S. Tesfaye et al.   DIABETES CARE

Beyond Hemoglobin A1c—Need for Additional Markers of Risk for Diabetic Microvascular Complications

(2010) Irl B. Hirsch   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

p38 Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes

(2010) Hsinlin T Cheng et al.   Molecular Pain

Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy

(2009) D. J. Wile et al.   DIABETES CARE

Microvascular Reactivity and Inflammatory Cytokines in Painful and Painless Peripheral Diabetic Neuropathy

(2009) John Doupis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort

(2009) Rodica Pop-Busui et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Pro-Inflammatory Mechanisms in Diabetic Neuropathy: Focus on the Nuclear Factor Kappa B Pathway

(2008) Norman Cameron et al.   CURRENT DRUG TARGETS

Rosiglitazone Treatment Reduces Diabetic Neuropathy in Streptozotocin-Treated DBA/2J Mice

(2008) Timothy D. Wiggin et al.   ENDOCRINOLOGY